Met with Jane Griffiths, Ph.D., Company Group Chairman, Europe, Middle East and Africa, for Janssen on the state of affairs in oncology.

Wonder what moves US Market Access? Here's my recent survey with 66 industry executives on the big item topics.

Time for an update on our working group, ‘The Aurora Project’ and our global patient-centricity survey with 2,346 responses.

Talking to CSL CEO Paul Perreault about the need for pharma to better connect with patients, drug pricing and CSL lessons for big pharma.

I recently met with U.S. President of Novartis , for a free-ranging chat about trust in pharma, patient input and driving value.

In September I met with over a dozen clinical leaders to discuss evolving roles of patients in clinical trials. Can we set a new paradigm?

A summary of a unique gathering of thought leaders to discuss the state of real world evidence, big data, HEOR and value-based interventions

Putting patient views and values at the heart of clinical research is key to a healthcare revolution. Here's an early roadmap for change.

With the shift from volume to value in the healthcare marketplace, we witness significant changes in the payment model coupled with moves...

"Homegrown Jihadi Terrorism – Examining the new 'Threat from Within' (2010)", München: AVM, ISBN: 978-3-89975-371-4, Paperback 68 pp.